OptimizeRx Stock

OptimizeRx Equity Ratio

The Equity Ratio of OptimizeRx (OPRX) as of Aug 22, 2026 is 72.52 %. In the previous year, Equity Ratio was 68.35 % — a change of 6.09% (higher).

Equity Ratio

72.52 %

YoY

6.09%

Last updated:

Equity Ratio of OptimizeRx is 2026 72.52 % . Equity Ratio of OptimizeRx was 2025 68.35 % . It decreases by 6.09% higher compared to the previous year.

The OptimizeRx Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
73.67 USD
Jan 1, 2019
79.21 USD
Jan 1, 2020
82.84 USD
Jan 1, 2021
93.19 USD
Jan 1, 2022
93.66 USD
Jan 1, 2023
69.01 USD
Jan 1, 2024
68.35 USD
Jan 1, 2025
72.52 USD
The OptimizeRx Equity Ratio history
YEAREquity RatioYoY
72.52 %+6.09%
68.35 %-0.96%
69.01 %-26.31%
93.66 %+0.50%
93.19 %+12.49%
82.84 %+4.58%
79.21 %+7.51%
73.67 %+15.64%
63.71 %-6.39%
68.06 %-6.28%
72.62 %+10.72%
65.59 %
Access this data via the Eulerpool API

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

Equity Ratio of OptimizeRx is 72.52 % in 2026.

Equity Ratio of OptimizeRx changed from 68.35 % to 72.52 %, representing a 6.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio OptimizeRx since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's OptimizeRx with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — OptimizeRx

All Key Metrics — OptimizeRx